Arthrosamid is a revolutionary treatment designed to provide long-lasting relief from knee osteoarthritis (OA). Unlike traditional treatments that focus on managing symptoms, Arthrosamid is a non-surgical injectable hydrogel that works by cushioning and lubricating the knee joint, improving mobility and reducing pain.
Arthrosamid is made up of 97.5% sterile water and 2.5% cross-linked polyacrylamide. When injected into the knee joint, the hydrogel integrates into the surrounding synovial tissue. This integration enhances joint lubrication and cushioning, alleviating pain and improving overall function.
Arthrosamid enhances lubrication in the joint, making movements smoother and less painful.
The treatment is administered via injection under local anesthesia, avoiding the need for surgery.
Clinical studies show that a single 6ml injection can provide pain relief lasting up to two years or more
Arthrosamid treatment is a new type of therapy for easing symptoms of knee pain caused by osteoarthritis. It involves an injection that contains non-biodegradable hydrogel, reducing pain and inflammation and offering patients safe and lasting relief. For individuals looking for effective, alternative treatments that don’t involve invasive knee replacement surgery, Arthrosamid could be the answer. Book a consultation today to discuss whether Arthrosamid is right for you.
Feature | Arthrosamid Treatment | Knee Surgery |
---|---|---|
Cost | One Knee £2,995 Both Knees £4,995 | £12,000 – £14,000 |
Procedure Type | Non-invasive | Invasive |
Recovery Time | Minimal | Weeks to months |
Effectiveness | Long-lasting relief | Variable |
Risk of Complications | Lower | Higher |
Arthrosamid is different from other injections for knee osteoarthritis due to it’s hydrogel composition. This has been designed to provide long-lasting relief. Unlike traditional steroid or hyaluronic acid injections, Arthrosamid acts to coat the lining of the joint (synovium) and thus provides a physical barrier to inflammation within the joint, improving mobility and reducing pain without frequent re-administration.
Arthrosamid, utilized as an intra-articular polyacrylamide hydrogel injection, provides a secure method for reducing knee osteoarthritis-related pain symptoms. Clinical trials have shown that the most frequent side effects are mild to moderate pain or swelling at the injection site, generally appearing in the first few weeks or months after the injection.
Osteoarthritis results in inflammation of the knee joint. Arthrosamid is injected into the knee joint capsule. It helps to restore the viscosity of the synovial fluid, thereby improving load distribution and lubrication. Once incorporated into the synovium of the inner joint capsule, Arthrosamid also creates a cushioning effect and acts as a physical barrier to inflammation.
Arthrosamid helps to cushion the joint and reduce inflammation, leading to a reduction in stiffness and pain, with improved movement. It is a safe treatment providing long-lasting relief and improving the overall quality of life.
Arthrosamid can reduce pain for up to a year, with preliminary studies indicating potential for several years of relief. Two major trials are currently monitoring patients over five years to fully assess Arthrosamid’s prolonged and sustained benefits.
Arthrosamid is administered through a 6ml injection and is designed to alleviate pain and stiffness while improving mobility. This leads to long-lasting pain relief and an enhanced quality of life. After receiving the injection, patients should refrain from strenuous activities for the first three to five days, a standard precaution following any invasive joint procedure. Temporary side effects from the injection, like mild to moderate pain or swelling at the injection site, particularly around the knee, may be experienced during the first week after the procedure.
Alternatively to speak to a member of our friendly team, please call 02079 657268 between 8am-8pm Monday to Friday.